Proteasome inhibitors: introduction

Semin Hematol. 2012 Jul;49(3):193-5. doi: 10.1053/j.seminhematol.2012.05.001.

Authors

Christoph J Heuck¹, John D Shaughnessy Jr

Affiliation

¹ Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

PMID: 22726541
DOI: 10.1053/j.seminhematol.2012.05.001

No abstract available

Publication types

Introductory Journal Article

MeSH terms

Antineoplastic Agents / pharmacology
Antineoplastic Agents / therapeutic use
Apoptosis / drug effects
Cell Proliferation / drug effects
Humans
Multiple Myeloma / drug therapy
Multiple Myeloma / metabolism
Multiple Myeloma / pathology
Proteasome Endopeptidase Complex / genetics
Proteasome Endopeptidase Complex / metabolism*
Proteasome Inhibitors / pharmacology*
Proteasome Inhibitors / therapeutic use
Structure-Activity Relationship

Substances

Antineoplastic Agents
Proteasome Inhibitors
Proteasome Endopeptidase Complex